Mitsubishi Electric to Transfer Shares of Insurance Subsidiary to Marsh Japan
TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it has concluded a share transfer agreement under which it will... Read more.
Brightstar Capital Partners to Acquire Arden University Stake
Partnership aims to scale Arden’s international reach, supercharge digital innovation and cement leadership position in higher education LONDON & NEW YORK–(BUSINESS... Read more.
Biocytogen Upgrades Preclinical Service Platform and Launches Revamped Global Website
BEIJING–(BUSINESS WIRE)–#AntibodyDiscovery–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company... Read more.
The Open Group Launches The Open Group Open Digital Transformation™ Forum
Standards body aims to spur faster, more effective transformation initiatives SAN FRANCISCO–(BUSINESS WIRE)–The Open Group, the vendor-neutral technology... Read more.
Bureau Veritas Partners with IFC’s Building Resilience Index to Expand Resilience Verification Services Globally
PARIS–(BUSINESS WIRE)–Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), has signed the first global verifier... Read more.
MaaT Pharma Secures €37.5 Million Loan From European Investment Bank (EIB) Marking a New Step in Advancing its Clinical Program in Hemato-Oncology
Tranche-based financing to support clinical development for the Company’s late-stage assets in hemato-oncology including Xervyteg® currently under review for... Read more.
Genentech and Roche Present New Insights in Alzheimer’s Disease Research Across Its Diagnostics and Pharmaceutical Portfolios at AAIC
– Trontinemab’s Phase Ib/IIa Brainshuttle™ AD study continues to show rapid and robust clearance of amyloid plaques, with 91% becoming amyloid PET negative... Read more.
Azafaros Announces Initiation of two Global Phase 3 studies with Nizubaglustat in Niemann-Pick disease Type C (NPC) and GM1/GM2 gangliosidoses, respectively
First patient dosed in global pivotal clinical trial program for late infantile/juvenile onset NPC and GM1/GM2 gangliosidoses. Both studies are part of Azafaros’... Read more.
Berkshire Hathaway Specialty Insurance Promotions in the Middle East
BOSTON & DUBAI, United Arab Emirates–(BUSINESS WIRE)–Berkshire Hathaway Specialty Insurance (BHSI) today announced that it has promoted Aisling Malone... Read more.
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: Company Has Received Over 10,000 Paid Pre-Orders for the FX Super One MPV as It Marks the 4th Anniversary of FFAI’s Public Listing
Faraday Future Hosts Successful Capitol Hill Club Reception in Washington D.C. on July 23 Showcasing Commitment to American Manufacturing and Innovation. LOS ANGELES–(BUSINESS... Read more.